Position in NVS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$600,864
+$68,225 QoQ
Shares Held
3,834
+10.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#809
of 1,603 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Foster Group, Inc. holds $10,581,491 across 11 Drug Manufacturers - General names. NVS ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,136 | $2,561,982 | |
| 2 | ABBV |
AbbVie Inc.
|
9,603 | $2,416,498 | |
| 3 | JNJ |
Johnson & Johnson
|
5,808 | $1,475,057 | |
| 4 | AMGN |
Amgen Inc
|
2,616 | $947,305 | |
| 5 | PFE |
Pfizer Inc
|
31,672 | $762,661 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,458 | $701,353 | |
| 7 | NVS |
Novartis AG
This page
|
3,834 | $600,864 | |
| 8 | AZN |
Astrazeneca PLC
|
2,053 | $389,289 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600,864 | 3,834 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $532,639 | 3,487 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $454,419 | 3,296 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $425,115 | 3,315 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $370,290 | 3,060 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $338,787 | 3,039 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $206,589 | 2,123 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $210,946 | 1,834 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||